Dengue Virus Disease

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2019-07-29
Clinical Trial Update: Study of ChimeriVax™ Tetravalent Dengue Vaccine in Healthy Peruvian Children Aged 2 to 11 Years [Phase 2]
Phase 2 trial update for the ChimeriVax tetravalent dengue vaccine in healthy children aged 2-11 years; study completed with results posted.